Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease
NCT02395783
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Premature Birth
Interventions
DRUG:
Melatonin 10 µg
DRUG:
Melatonin 20 µg
OTHER:
Placebo
Sponsor
Assistance Publique - Hôpitaux de Paris